Compare Injective (INJ) vs Suilend (SEND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Suilend — how do they compare? Injective trades at Rp81,611 (market cap Rp8,14T, Rp770,73M 24h volume), while Suilend trades at Rp882.28 (market cap Rp65,02M, Rp1,62M 24h volume). The key difference: Injective is far larger — about 125192.2× Suilend's market cap, and Suilend's supply is capped (70,6M / 100M SEND (71%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Suilend for 14 Days on average.
| INJ | SEND | |
|---|---|---|
Market Cap | Rp8,14T | Rp65,02M |
Volume (24h) | Rp770,73M | Rp1,62M |
Circulating Supply | 100M INJ | 70,6M / 100M SEND (71%) |
Typical Hold Time | 37 Days | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Suilend (SEND) currently holds a market capitalization of approximately Rp65.02 million with a circulating supply of 70.6 million tokens out of a maximum 100 million, indicating a 71% circulation rate. The asset exhibits a short average hold time of 14 days, suggesting active trading. No recent price or volume data is available for technical trend analysis, and there are no significant protocol updates or ecosystem news reported.
The outlook for SEND is characterized by uncertainty due to the absence of current trading data and recent developments. Key opportunities lie in its fully diluted valuation potential, while major risks include low liquidity, high volatility typical of micro-cap tokens, and a lack of visible network activity or community engagement.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Suilend
Suilend has quickly become a key DeFi platform on Sui since its launch in March. It is now expanding into the Sui DeFi Suite with lending, LSTs, swaps, and AMMs to create a full DeFi superapp.
Read more on SEND →
